Efficacy Trial of Zonisamide for Myoclonus Dystonia

Summary

Myoclonus Dystonia is a disease in which myoclonus distort the precision of movements and so cause a handicap in the movements of the everyday life. Response to oral medications may be incomplete and surgery may cause operating risk. Zonisamide is an antiepileptic drug which could bring a therapeutic profit in Myoclonus Dystonia on the severity of the myoclonus.

Timeline

Start

2012-02

Primary completion

2014-07

Completion

2014-07

Drugs

Indications